Growth Metrics

Lifevantage (LFVN) Liabilities and Shareholders Equity (2016 - 2026)

Lifevantage filings provide 15 years of Liabilities and Shareholders Equity readings, the most recent being $61.2 million for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 10.74% to $61.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $271.9 million, a 8.09% increase, with the full-year FY2025 number at $72.0 million, up 19.34% from a year prior.
  • Liabilities and Shareholders Equity hit $61.2 million in Q4 2025 for Lifevantage, down from $61.6 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $78.7 million in Q2 2021 to a low of $60.3 million in Q2 2024.
  • Median Liabilities and Shareholders Equity over the past 5 years was $67.7 million (2022), compared with a mean of $68.3 million.
  • Biggest five-year swings in Liabilities and Shareholders Equity: soared 43.54% in 2021 and later fell 10.74% in 2025.
  • Lifevantage's Liabilities and Shareholders Equity stood at $72.2 million in 2021, then dropped by 6.11% to $67.8 million in 2022, then fell by 7.59% to $62.7 million in 2023, then increased by 9.32% to $68.5 million in 2024, then decreased by 10.74% to $61.2 million in 2025.
  • The last three reported values for Liabilities and Shareholders Equity were $61.2 million (Q4 2025), $61.6 million (Q3 2025), and $72.0 million (Q2 2025) per Business Quant data.